Valerio DiTizio - Covalon Technologies Insider

CVALF -- USA Stock  

USD 6.42  0.14  2.13%

Co-Founder and Chief Science Officer

Dr. Valerio DiTizio serves as a Chief Scientific Officer of Covalon Technologies Ltd., since December 21, 2004. Dr. DiTizio is a coinventor of Covalon technologies and a cofounder of the company. He has degrees in science from the University of Toronto as a Biochemistry Specialist. Dr. DiTizio completed his Master degree in liposome drug delivery. His graduate research involved the application of polymer chemistry and drug delivery in pursuit of novel materials and processes that currently comprise the core of Covalons intellectual property. Dr. DiTizio holds several US and European patents.
Age: 48  Founder Since 2004      
905-568-8400  http://www.covalon.com

Management Efficiency

The company has return on total asset (ROA) of 4.93 % which means that it generated profit of $4.93 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.97 % meaning that it generated $10.97 on every $100 dollars invested by stockholders.

Entity Summary

Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical technologies and products worldwide. The company offers its technologies, products, and services to various health care providers, such as hospitals, wound care centers, burn centers, extendedalternate care facilities, acute care facilities, home health care agencies, and physicians offices. Covalon Technologies operates under Biotechnology classification in USA and traded on OTC Market.Covalon Technologies Ltd (CVALF) is traded on OTC Market in USA. It is located in 1660 Tech Avenue and employs 6 people.

Covalon Technologies Leadership Team

Elinor Caplan, Director
Murray Miller, Director
John Hands, Director
Kim Crooks, VP
Gale Pollock, Director
Jeffrey Mandel, Director
Ian Brindle, Director
Joseph Cordiano, Director, MBA
Valerio DiTizio, Founder
Danny Brannagan, CFO
Brian Pedlar, CEO
Abe Schwartz, Chairman
Martin Bernholtz, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now
   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Portfolio Suggestion

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Covalon Technologies and Ecopetrol S A. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.